3SBio Inc. (OTCMKTS:TRSBF – Get Free Report) was the recipient of a significant growth in short interest during the month of May. As of May 29th, there was short interest totaling 2,443,617 shares, a growth of 345.1% from the May 14th total of 549,065 shares. Based on an average trading volume of 12,127 shares, the short-interest ratio is currently 201.5 days.
3SBio Price Performance
Shares of OTCMKTS:TRSBF opened at $2.20 on Friday. The business’s 50 day moving average price is $2.72 and its 200-day moving average price is $3.01. 3SBio has a 1 year low of $2.00 and a 1 year high of $4.74.
About 3SBio
3SBio Inc (OTCMKTS: TRSBF) is a China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of protein-based therapeutics and chemical drugs. Established in 1999 and headquartered in Shenyang, Liaoning Province, the company has built an integrated platform that encompasses in-house R&D capabilities, clinical development, commercial production and a nationwide sales network.
The company’s product portfolio features a range of hematopoietic growth factors such as recombinant human granulocyte colony-stimulating factor (rhG-CSF) and recombinant human erythropoietin (rhEPO), insulin and insulin analogs, hemostasis agents and monoclonal antibodies.
See Also
- Five stocks we like better than 3SBio
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for 3SBio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 3SBio and related companies with MarketBeat.com's FREE daily email newsletter.
